50th week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200383964 | MITOCHONDRIA TARGETING, MPTP REGULATION, AND THE REDUCTION OF MITOCHONDRIAL REACTIVE SPECIES | 2020-12-10 |
20200383965 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | 2020-12-10 |
20200383966 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | 2020-12-10 |
20200383967 | Novel Anthranilic Acid-Based Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same | 2020-12-10 |
20200383968 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VASOMOTOR SYMPTOMS | 2020-12-10 |
20200383969 | RIMEGEPANT FOR CGRP RELATED DISORDERS | 2020-12-10 |
20200383970 | Morphinan Derivatives with High Oral Bioavailability | 2020-12-10 |
20200383971 | CANCER TREATMENT | 2020-12-10 |
20200383972 | TEMOZOLOMIDE POWDER FORMULATION | 2020-12-10 |
20200383973 | MECLOZINE DERIVATIVES AND DICLAZURIL DERIVATIVES FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF DISORDERS ASSOCIATED TO THE INFLAMMATION INDUCED BY P. ACNES | 2020-12-10 |
20200383974 | METHOD FOR TREATING CANCER USING A BCL-2 INHIBITOR IN CONJUNCTION WITH AN ALPHA-EMITTING RADIOIMMUNOTHERAPEUTIC | 2020-12-10 |
20200383975 | TOPICAL FORMULATIONS FOR DELIVERY OF HEDGEHOG INHIBITOR COMPOUNDS AND USE THEREOF | 2020-12-10 |
20200383976 | TREATMENT OF SCHIZOPHRENIA | 2020-12-10 |
20200383977 | STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 2020-12-10 |
20200383978 | METHODS FOR INDUCING PUPIL DILATION | 2020-12-10 |
20200383979 | TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES | 2020-12-10 |
20200383980 | METHODS OF USE AND PHARMACEUTICAL COMBINATIONS COMPRISING HISTONE DEACETYLASE INHIBITORS AND JAK1/2 INHIBITORS | 2020-12-10 |
20200383981 | Anti-Tumor Immunotherapy Enhancer | 2020-12-10 |
20200383982 | PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS | 2020-12-10 |
20200383983 | CGRP ANTAGONISTS FOR THE TREATMENT OF MEDICATION OVERUSE HEADACHE, POST-TRAUMATIC HEADACHE, POST-CONCUSSION SYNDROME AND VERTIGO | 2020-12-10 |
20200383984 | HETEROARYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE | 2020-12-10 |
20200383985 | Inhibitors of Protease Activated Receptor-2 | 2020-12-10 |
20200383986 | TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR | 2020-12-10 |
20200383987 | Novel Amide Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same | 2020-12-10 |
20200383988 | Compounds | 2020-12-10 |
20200383989 | Therapeutic Agent for Fatty Liver Diseases and Therapeutic Agent for Adiposity | 2020-12-10 |
20200383990 | METHODS OF TREATING CANCER WITH PLK4 INHIBITORS | 2020-12-10 |
20200383991 | 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES | 2020-12-10 |
20200383992 | METHOD FOR SMOKING CESSATION | 2020-12-10 |
20200383993 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | 2020-12-10 |
20200383994 | PREVENTION AND TREATMENT OF VIRAL INFECTIONS | 2020-12-10 |
20200383995 | COMBINATIONS OF RIPK1- AND IKK-INHIBITORS FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES | 2020-12-10 |
20200383996 | TREATING CANCER WITH A CCK RECEPTOR INHIBITOR AND AN IMMUNE CHECKPOINT INHIBITOR | 2020-12-10 |
20200383997 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2020-12-10 |
20200383998 | Liver Disease | 2020-12-10 |
20200383999 | STEROIDAL COMPOSITIONS | 2020-12-10 |
20200384000 | Methods of Treating Residual Lesions of Vascular Anomalies | 2020-12-10 |
20200384001 | COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROINFLAMMATORY DISEASE, CONTAINING PROTEIN TYROSINE PHOSPHATASE | 2020-12-10 |
20200384002 | Prodrugs Activated by Reduction in the Cytosol | 2020-12-10 |
20200384003 | TRITERPENOID-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020-12-10 |
20200384004 | METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA | 2020-12-10 |
20200384005 | ZIKA VIRUS PROTEASE INHIBITORS AND METHODS OF USE THEREOF | 2020-12-10 |
20200384006 | METHODS OF TREATING CANCER USING PRMT5 INHIBITORS | 2020-12-10 |
20200384007 | LIPID NANOPARTICLES CONTAINING PHARMACEUTICAL AND/OR NUTRACEUTICAL AGENTS AND METHODS THEREOF | 2020-12-10 |
20200384008 | Cytochrome P450 Enzyme Complexes And Methods Of Treatment Using The Same | 2020-12-10 |
20200384009 | A3 ADENOSINE RECEPTOR LIGAND FOR USE IN TREATING ECTOPIC FAT ACCUMULATION | 2020-12-10 |
20200384010 | COMPLEX OF NUCLEIC ACID MEDICINE AND MULTIBRANCHED LIPID | 2020-12-10 |
20200384011 | POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF | 2020-12-10 |
20200384012 | PENTOSAN POLYSULFATE AND MEDICINE CONTAINING PENTOSAN POLYSULFATE | 2020-12-10 |
20200384013 | COMPOSITION FOR IMPROVEMENT OF SYMPTOMS OF SPINAL CORD INJURY | 2020-12-10 |
20200384014 | Pulsed Administration Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension | 2020-12-10 |
20200384015 | MAGNESIUM/LITHIUM PREPARATIONS FOR NEUROPROTECTION AND NEUROTROPHIC BENEFITS | 2020-12-10 |
20200384016 | PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES | 2020-12-10 |
20200384017 | COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING MATERIALS FOR FOLLICULAR DELIVERY | 2020-12-10 |
20200384018 | OZONE NANOBUBBLE ANTICANCER AGENT | 2020-12-10 |
20200384019 | DIALYSIS SOLUTION, FORMULATED AND STORED IN TWO PARTS, COMPRISING PHOSPHATE | 2020-12-10 |
20200384020 | IMMUNE CELLS WITH MODIFIED METABOLISM AND THEIR USE THEREOF | 2020-12-10 |
20200384021 | HIV IMMUNOTHERAPY WITH NO PRE-IMMUNIZATION STEP | 2020-12-10 |
20200384022 | METHODS AND COMPOSITIONS FOR TARGETING DEVELOPMENTAL AND ONCOGENIC PROGRAMS IN H3K27M GLIOMAS | 2020-12-10 |
20200384023 | Antibody Or Antigen Binding Fragment Thereof For Specifically Recognizing B Cell Malignancy, Chimeric Antigen Receptor Comprising Same And Use Thereof | 2020-12-10 |
20200384024 | T-CELLS COMPRISING ANTI-CD38 AND ANTI-CD138 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | 2020-12-10 |
20200384025 | PROCESS FOR PRODUCING A COMPOSITION OF ENGINEERED T CELLS | 2020-12-10 |
20200384026 | RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | 2020-12-10 |
20200384027 | METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY | 2020-12-10 |
20200384028 | SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES | 2020-12-10 |
20200384029 | DUAL CAR EXPRESSING T CELLS INDIVIDUALLY LINKED TO CD28 AND 4-1BB | 2020-12-10 |
20200384030 | CHIMERIC TRANSMEMBRANE RECEPTORS AND USES THEREOF | 2020-12-10 |
20200384031 | ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY | 2020-12-10 |
20200384032 | METHOD FOR INCREASING FETAL HEMOGLOBIN EXPRESSION LEVEL | 2020-12-10 |
20200384033 | CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS AND USES THEREOF | 2020-12-10 |
20200384034 | METHODS FOR ATTENUATING VIRAL INFECTION AND FOR TREATING LUNG INJURY | 2020-12-10 |
20200384035 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS COMPRISING CLONAL STEM CELLS | 2020-12-10 |
20200384036 | MEDIUM COMPOSITION FOR CELL PROLIFERATION, SKIN REGENERATION, AND WRINKLE IMPROVEMENT COMPRISING, AS ACTIVE INGREDIENT, CONDITIONED MEDIUM OF PLURIPOTENT STEM CELLS, NEURAL STEM CELLS, OR EMBRYONIC FIBROBLASTS WHICH ARE ISOLATED FROM AVIAN EGGS | 2020-12-10 |
20200384037 | COMPOSITIONS AND METHODS FOR INHIBITING SEIZURES | 2020-12-10 |
20200384038 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2020-12-10 |
20200384039 | MEGAMONAS FUNIFORMIS AND APPLICATIONS THEREOF | 2020-12-10 |
20200384040 | USE OF BACTEROIDES FRAGILIS IN PREPARATION OF MEDICAMENT FOR TREATING AND PREVENTING TUMOR | 2020-12-10 |
20200384041 | SPRAY-DRIED SIALYLLACTOSE | 2020-12-10 |
20200384042 | TRIBUTYRIN COMPOSITIONS AND METHODS THEREFOR | 2020-12-10 |
20200384043 | Tributyrin Compositions And Methods Therefor | 2020-12-10 |
20200384044 | METHOD OF DETECTING FUNCTIONAL GASTROINTESTINAL DISORDER BY MEASURING GASTRIC FLORA OCCUPANCY, AND GASTRIC FLORA IMPROVING AGENT | 2020-12-10 |
20200384045 | Rotary Separation Apparatus and Process | 2020-12-10 |
20200384046 | COMPOSITION FOR IMPROVING SKIN DAMAGE BY FINE DUST COMPRISING CULTURE OR ITS EXTRACT OF AUREOBASIDIUM PULLULANS | 2020-12-10 |
20200384047 | Method of Making a Dietary Supplement | 2020-12-10 |
20200384048 | COMPOUND AND METHOD FOR TREATMENT OF MOVEMENT DISORDERS | 2020-12-10 |
20200384049 | COMPOUND AND METHOD FOR TREATMENT OF MOVEMENT DISORDERS | 2020-12-10 |
20200384050 | Data Centre | 2020-12-10 |
20200384051 | HERBAL FORMULATIONS OF CARNIVOROUS PLANTS AND METHODS FOR TREATING INFLAMMATION | 2020-12-10 |
20200384052 | ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION | 2020-12-10 |
20200384053 | Ophthalmic Compositions and Medical Uses Thereof in Treatment of Myopia | 2020-12-10 |
20200384054 | EXTRACTS OF CYNARA CARDUNCULUS AND CITRUS AURANTIUM BERGAMIA, COMBINATIONS THEREOF, AND FORMULATIONS CONTAINING THEM | 2020-12-10 |
20200384055 | Topical Skin Care Compositions | 2020-12-10 |
20200384056 | COMPOSITION FOR PREVENTING OR ALLEVIATING HANGOVER, CONTAINING LONGAN ARILLUS EXTRACT | 2020-12-10 |
20200384057 | COMPOSITION FOR ENHANCING IMMUNITY OR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES BY USING GOJI BERRIES, MULBERRIES AND JUJUBES | 2020-12-10 |
20200384058 | COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, GREEN TEA EXTRACT WITH INCREASED POLYSACCHARIDE CONTENT | 2020-12-10 |
20200384059 | COMPOSITION FOR PROSTAGLANDIN TRANSPORTER INHIBITION AND RELATED THERAPEUTIC APPLICATIONS | 2020-12-10 |
20200384060 | PHARMACEUTICAL COMPOSITION MADE FROM HYDROPHOBIC PHYTOCHEMICALS DISPERSED IN SESAME OIL TO ENHANCE BIOACTIVITY | 2020-12-10 |
20200384061 | Fusion Protein Including BDNF | 2020-12-10 |
20200384062 | USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION | 2020-12-10 |
20200384063 | USE OF TETRASPANIN-2 FOR TREATING DIABETES AND SCREENING AN ANTI-DIABETIC AGENT | 2020-12-10 |